Efficacy and Safety of Saxagliptin VS. Glimepiride in Chinese T2DM Patients Controlled Inadequately With Metformin

PHASE4CompletedINTERVENTIONAL
Enrollment

388

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2017

Conditions
Type 2 Diabetes
Interventions
DRUG

Saxagliptin

5 mg/d

DRUG

Glimepiride

1mg/d, up titrated 1mg if FPG \>6.1 mmol/L (110mg/dL) till 6 mg

Trial Locations (1)

210008

at Division of Endocrinology, the Affiliated Drum Tower Hospital of Nanjing University, Nanjing

All Listed Sponsors
collaborator

The First Affiliated Hospital with Nanjing Medical University

OTHER

collaborator

Zhongda Hospital

OTHER

collaborator

Nanjing PLA General Hospital

OTHER

collaborator

Changzhou No.2 People's Hospital

OTHER

collaborator

The First Affiliated Hospital of Soochow University

OTHER

collaborator

Wuxi People's Hospital

OTHER

collaborator

The First Affiliated Hospital of Anhui Medical University

OTHER

collaborator

Huai'an First People's Hospital

OTHER

lead

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

OTHER

NCT02280486 - Efficacy and Safety of Saxagliptin VS. Glimepiride in Chinese T2DM Patients Controlled Inadequately With Metformin | Biotech Hunter | Biotech Hunter